---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038590"
form_type: "8-K"
ticker: "KAPA"
cik: "0001962011"
company_name: "Kairos Pharma, LTD."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:18:57.038042+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Kairos Pharma enters two service agreements: $615K cash + 50K RSUs

## Summary
- CEO.CA Technologies to provide advertising and consulting for $250,000 over 12 months.
- Belair Capital Advisors to provide strategic advisory for $365,000 plus 50,000 RSUs vesting in 6 months.
- Services include digital marketing, market research, business development assistance, and stakeholder communication.
- Both agreements are governed by Ontario law and contain standard indemnification clauses.

## SEC filing metadata
- accession: 0001493152-24-038590
- form_type: 8-K
- ticker: KAPA
- cik: 0001962011
- company_name: Kairos Pharma, LTD.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1962011/000149315224038590/0001493152-24-038590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1962011/000149315224038590/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038590
- JSON: https://secwatch.observer/filing/0001493152-24-038590.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038590.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.